• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Vu Q&A Page 4

Vu Q&A

July 28, 2021

U.S. Congresswoman Grace Meng on Funding Viral Hepatitis Surveillance and the Congressional Hepatitis Caucus

July 28, 2021

Jim Macrae on Health Disparities in Viral Hepatitis Elimination

Read More

May 25, 2021

APIAHF on HIV and Viral Hepatitis in the AANHPI Community

Read More

March 3, 2021

Dr. Eric Hall on County-Level Hepatitis C-Related Mortality Trends in the U.S.

Read More

May 18, 2020

Vu Q&A: Lauren Canary on Hepatitis Surveillance During COVID-19

Read More

May 18, 2020

Vu Q&A: Lance Toma on Health Disparities in the API Community

Read More

January 14, 2020

Vu Q&A: Dr. Heather Bradley on Hep C by Race, Sex, and Age

Read More

December 2, 2019

Vu Q&A: Monica Graybeal on Ending Hep C in Washington State

Read More

October 3, 2019

Vu Q&A: Dr. John Ward on Global Hepatitis Elimination

Read More

July 11, 2019

Vu Q&A: Sonia Canzater and Jeff Crowley on Hepatitis C and the Ryan White HIV/AIDS Program

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.